Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
Kimia Farma Tbk.
KAEF
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
4
ROE
0,71%
ROA
0,14%
Book Value
520
Net Income
10,33 M
Total Sales
4,70 T
Total Assets
14,70 T
DER
4.11x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
5,75%
89,82%
Tentang Perusahaan
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Produk & Lini Bisnis
The scope of company’s activities comprises of among others, manufacture and distribution of pharmacy, chemical, biology, healthy, food/drink and apotek.
Dewan Direksi
DP
Djagad Prakasa Dwialam
President Director
LS
Lina Sari
Director
HK
Hadi Kardoko
Director
DR
Disril Revolin Putra
Director
JK
Jasmine Karsono
Director
CH
Chairani Harahap
Director
Dewan Komisaris
SL
Stefan Lohoo
President Commissioner / Indp
MF
Mustofa Fauzi
Independent Commissioner
S
Suprianto
Commissioner
WA
Wiku Adisasmito
Commissioner
FI
Fachmi Idris
Independent Commissioner
DK
Diah Kusumawardani
Independent Commissioner
Anak Usaha & Afiliasi
| Nama | Domisili | % |
|---|---|---|
| PT Kimia Farma Apotek Pharmacy |
Jakarta | 99.99% |
| PT Kimia Farma Trading & Distribution Medicine Distribution |
Jakarta | 99.99% |
| PT Sinkona Indonesia Lestari Quinine Factory |
Subang | 51.00% |
| PT Kimia Farma Sungwun Pharmacopia Raw Materials Medicine |
Jakarta | 75.00% |
| PT Kimia Farma Dawaa Co. Ltd Pharmacy and Medicine Distribution |
Arab Saudi | 60.00% |
Trend Keuangan (5 periode terakhir)
— hover bar untuk detail
Total Sales
Net Income (+)
Net Income (-)
2025 Q2
EPS -34
ROE -5,70%
2025 Q3
EPS -43
ROE -7,38%
2025 Q4
EPS -60
ROE -11,61%
2026 Q1
EPS 54
ROE 10,06%
2026 Q2
EPS 4
ROE 0,71%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
| Periode | Total Sales | Net Income | Total Assets | Total Equity | EPS | ROE | DER |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 4,70 T | 10,33 M | 14,70 T | 2,90 T | 4 | 0,71% | 4.11x |
| 2026 Q1 | 2,03 T | 74,45 M | 14,36 T | 2,96 T | 54 | 10,06% | 3.88x |
| 2025 Q4 | 9,22 T | -334,96 M | 14,18 T | 2,89 T | -60 | -11,61% | 3.97x |
| 2025 Q3 | 7,01 T | -179,73 M | 14,91 T | 3,25 T | -43 | -7,38% | 3.61x |
| 2025 Q2 | 4,37 T | -95,02 M | 14,97 T | 3,33 T | -34 | -5,70% | 3.51x |
History Harga Penutupan & Book Value
| Tahun | Qrt | Close Price (Rp) | Book Value (Rp) | ROA |
|---|---|---|---|---|
| 2026 | 2 | 420 | 520 | 0,14% |
| 2026 | 1 | 462 | 532 | 2,07% |
| 2025 | 4 | 515 | 518 | -2,36% |
| 2025 | 3 | 540 | 583 | -1,61% |
| 2025 | 2 | 675 | 599 | -1,27% |
Data diperbarui pada: 2026-05-12 10:55:29